First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – the biologic adrulipase, a recombinant lipase enzyme designed to enable the
Alcresto
Alcresta develops rare disease, enzyme-based products helping to address fat malabsorption in patients who are enterally fed at home or in the hospital. Our RELiZORB® (immobilized lipase) is indicated for use in pediatric patients (ages 5+) and adult patients to hydrolyze fats in enteral formula. Please see Instructions for Use at wwww.relizorb.com.
4D Molecular Therapeutics
4DMT is a clinical stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases. 4DMT seeks to unlock the full potential of genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution, which combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV
Walgreens
Walgreens
Foundation Care Specialty Pharmacy
Foundation Care is a specialty pharmacy providing personalized care to help patients living with CF maximize their quality of life. We are proud to be part of the CF care team, focused on the unique and individual needs of the patient. We offer: Limited distribution drugs and biosimilars access Therapy management support from our pharmacists
Boomer Esiason Foundation
The Boomer Esiason Foundation is a dynamic partnership of leaders in the medical and business communities joining with a committed core of volunteers to heighten awareness, education and quality of life for those affected by cystic fibrosis, while providing financial support to research aimed at finding a cure.
AbbVie
Exocrine Pancreatic Insufficiency (EPI) is a condition in which your body doesn’t provide enough pancreatic enzymes to properly break down food. People with EPI are unable to properly digest the nutrients in food such as fats, proteins, and carbohydrates, leading to maldigestion. Once diagnosed, EPI is a manageable condition when treated with pancreatic enzyme replacement
BRONCHITOL (mannitol) inhalation powder
BRONCHITOL (mannitol) inhalation powder
Gilead
To discover, develop and deliver innovative therapeutics for people with life-threatening diseases.
Genentech
For more than 45 years, we have been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions. We focus our research and development practice on discovering and developing new medicines for unmet medical needs.